Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China-Biotics Says New Plant Delayed

publication date: Jan 14, 2009

China-Biotics, a probiotics company, reported that construction of its new manufacturing plant in Shanghai has been delayed. The company blamed the delay on regulatory conflicts. Two agencies have jurisdiction over the facility, the SFDA and the Shanghai Municipal Bureau of Quality and Technical Supervision, each of which requires a different certification standard. Until the differing requirements can be resolved, China-Biotics has slowed down the installation of equipment. More details...

Stock Symbol: (NSDQ: CHBT)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital